Latest American Medical Association Stories
A large study addressing the effectiveness and safety of aldosterone antagonist therapy for older heart failure patients has found notable differences between the drug's results in clinical trial vs. what occurs in actual practice.
BioCardia, Inc., focused on regenerative biologic therapies for cardiovascular disease, today announced positive results from a Phase 1/2 heart failure trial using the Company's Helical Infusion System, comprising the Helical Infusion System Catheter™ and Morph® Vascular Access Catheter, to deliver allogeneic, or "off-the-shelf," and autologous, or from the treated patient, mesenchymal (adult) stem cells (MSCs) via transendocardial injection.
Hispanic Community Health Study/Study of Latinos (HCHS-SOL) — which will be presented at the American Heart Association Annual Meeting in Los Angeles on Nov. 5 and published in the Nov. 7 issue of the Journal of the American Medical Association (JAMA) — finds heart disease risk factors are widespread among Hispanic/Latino adults in the United States.
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow.
A study published in today's [Monday, Oct. 29] Archives of Internal Medicine finds that per capita Medicare spending on the elderly has grown nearly three times faster in the United States than in Canada since 1980.
Although bariatric surgery results in greater weight loss than conventional measures, new research shows this does not translate into significantly greater improvement in obstructive sleep apnea (OSA).
New York medical malpractice lawyer David Perecman supports the new government initiative that invites and facilitates the reporting of medical errors by patients.
The Journal of the American Medical Association (JAMA) is a peer-reviewed medical journal published weekly by the American Medical Association. It was established in 1883 with Nathan Smith Davis as the first editor of the journal. As of May 2012, the editor in chief is Howard C. Bauchner MD (Boston University's School of Medicine). JAMA is published in English, French and Spanish. JAMA publishes original research, reviews, commentaries, editorials, essays, medical news, correspondence, and...
- An armed gangster.